March 15 (Reuters) - Cidara Therapeutics Inc
* Cidara therapeutics inc - qtrly basic and diluted net loss per share $0.88
* Cidara therapeutics inc - cash, cash equivalents and short-term investments totaled $104.6 million as of december 31, 2016 - sec filing Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.